ASHI 2012 – San Juan, Puerto Rico

13/10/2012

Omixon presented its poster, “HLA Typing from Next Generation Sequencing data,” at the 38th Annual Meeting of American Society for Histocompatibility and Immunogenetics in San Juan, Puerto Rico. CEO, Attila Bérces, PhD and VP of Sales and Marketing, Fred Eberlein, attended the conference.

Feature list for Omixon Target version 1.1

10/10/2012

Finally, it”s a pleasure to introduce the new features of the version 1.1: HLA results visualization (short reads pileup) “Create HG19 profile” function for custom analysis New dashboard and other ergonomic improvements Improved HLA typing results for Ion Torrent and Roche 454 data Targeted import and analysis of mapped...

GenomeWeb Features Omixon Again!

03/10/2012

It was a great pleasure to see GenomeWeb features Omixon Target again in a new article in which they describe Vendors are Cautiously Optimistic as Illumina Readies BaseSpace App Store. Omixon, for instance, is developing an HLA genotyping application for identifying disease associations using whole-genome or whole-exome data as well as from targeted...

Almac performs Next Generation Sequencing for Omixon

19/09/2012

BusinessWire published an article about Almac and Omixon. Almac is launching a Next Generation Sequencing service to support the development of personalized medicine and collaborates with Omixon. Almac already perform Next Generation Sequencing for Omixon, a bioinformatics company focused on the development of validated data analysis solutions to scientists working in...

23 Aug 2012 NGS Workshop at Harvard Medical School

24/08/2012

We are grateful for the many researchers and genetists who attended our workshop on August 23, 2012 at Harvard Medical School. Omixon’s CEO, Attila Berces, initiated the workshop with a presentation of how targeted analysis differs from whole genome analysis. The participants were able to test Omixon Target during...